by neoncadmin | May 26, 2022 | NEO 100, Publications
Postsurgical Biopsy Shows Viability of NEO 100 Internasal Delivery May 26, 2022 Detection of Perillyl Alcohol and Its Metabolite Perillic Acid in Postsurgical Glioblastoma Tissue After Intranasal Administration of NEO100 Authors: Axel H. Sch€onthal, PhD,1, Steve...
by neoncadmin | Feb 28, 2021 | NEO 100
NEO-100 Enhances Delivery Of Herceptin For Treatment Of Metastatic Breast Cancer In The Brain February 28, 2021 Enhanced Brain Delivery And Therapeutic Activity Of Trastuzumab After Blood-Brain Barrier Opening By NEO100 In Mouse Models Of Brain-Metastatic Breast...
by neoncadmin | Oct 23, 2020 | NEO 100
NEO 100 Human Trial In Adult Patients With Recurrent Glioblastoma October 23, 2020 Phase 1 Trial Of Intranasal Neo 100, Highly Purified Perillyl Alcohol, In Adult Patients With Recurrent Glioblastoma. Authors: Axel Schonthal, PhD 1, David M Peereboom3, Naveed Wagle4,...
by neoncadmin | Sep 2, 2020 | NEO 100
Further Study Supporting NEO 100's Ability To Safely Deliver Therapeutics Through The Blood Brain Barrier September 2, 2020 NEO100 enables brain delivery of blood-brain barrier impermeable therapeutics. Authors: Weijun Wang1, Nagore I. Marín-Ramos1, Haiping He1,2,...
by neoncadmin | Jun 24, 2020 | NEO 100
Improving Therapeutic Efficacy For Brain-Based Cancers Using NEO 100 NEO 100 Enables Brain Delivery Of Blood-Brain Barrier-Impermeable Therapeutics. Authors: Weijun Wang 1, Nagore I. Marín-Ramos1, Haiping He1,2, Shan Zeng1,2, Hee-Yeon Cho1, Stephen D. Swenson1, Long...
by neoncadmin | Mar 28, 2019 | NEO 100
NEO 100 Enables Noninvasive, Therapeutically Effective Delivery of Pharmaceutical Agents Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models Authors: Weijun Wang, MD1,...
